# Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

> **NCT02474368** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 21 (actual)

## Conditions studied

- Recurrent Head and Neck Carcinoma
- Head and Neck Cancer Metastatic
- Head or Neck Cancer

## Interventions

- **RADIATION:** Intensity Modulated Radiation Therapy (IMRT)
- **DRUG:** Cisplatin
- **RADIATION:** Stereotactic Body Radiotherapy (SBRT)

## Key facts

- **NCT ID:** NCT02474368
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-11
- **Primary completion:** 2021-01
- **Final completion:** 2026-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02474368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02474368, "Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02474368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*